Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Galmed Pharmaceuticals Ltd. buy Roth Mkm

Galmed Pharmaceuticals Ltd.
Start price
€6.40
17.12.24 / 50%
Target price
€109.50
17.12.25
Performance (%)
-
End price
-
18.12.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Galmed Pharmaceuticals Ltd. - - -
iShares Core DAX® 0.437% 5.640% 7.806%
iShares Nasdaq 100 1.057% 0.282% 27.239%
iShares Nikkei 225® 1.769% 0.406% 49.266%
iShares S&P 500 0.368% 1.920% 22.336%

Comments by Roth_Mkm for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 109.503
Change
Ends at 17.12.25

Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat

Roth Mkm 
0
Report Share
17.12.24
In the thread Trading Galmed Pharmaceuticals Ltd.
Prediction Buy
Perf. (%) -
Target price 109.503
Change
Ends at 17.12.25

Die von Roth_Mkm gewählte maximale Laufzeit wurde überschritten

Roth Mkm 
0
Report Share
18.12.25

Stopped prediction by Roth_Mkm for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
06.11.24
€93.12
06.11.25
-
07.11.25

Roth Mkm 
06.11.24 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.39
20.10.23
€70.85
20.10.24
1558.03%
21.10.24

Roth Mkm 
20.10.23 50%